arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Lucid Diagnostics Inc.

LUCD

$0.39 ▼ -0.06 (-13.43%) at close

7 Visible periods

24 Metrics

Absolute Benchmarks

Price Chart

Health

Weak

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Lucid Diagnostics Inc. shows weak fundamentals, weighed down by Return on Invested Capital and FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $39.8M

Dividend Yield —

Revenue Growth 8.3% ↘

Op. Margin —

ROIC -453.9% ↗

FCF / Share $-0.46 ↗

Trailing P/E —

Price / Book 4.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$4.71M

↑ +8.3% —

Net Income Profit after all expenses

$-58.01M

↓ -27.4% —

FCF / Share Free cash flow per share

$-0.46

↑ +47.9% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -453.9% is weak on an absolute basis (target > 10%)
FCF / Net IncomeFCF / Net Income of 0.80x is caution on an absolute basis (target > 1x)

Health Breakdown

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	8.3% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: At sector avg	79.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+887%)	544.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6700%)	-24.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-408%)	—	—	—
EPS Growth YoY (%)	34.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	16.7% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	18.7% Good Good Year-over-year change in earnings per share Optimal: > 10%	-2.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—
Net Income Growth YoY (%)	-27.4% Weak → Weak Stable Year-over-year change in net income	13.6% Fair ↑ Fair Improving Year-over-year change in net income	6.2% Fair ↑ Fair Improving Year-over-year change in net income	-100.1% Weak Weak Year-over-year change in net income	-239.1% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	47.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-11.9% Weak ↓ Weak Declining Year-over-year change in free cash flow	13.6% Fair Fair Year-over-year change in free cash flow	4.3% Caution Caution Year-over-year change in free cash flow	—	—	—
Revenue CAGR 3Y (%)	132.0% Excellent Excellent Compound annual revenue growth over 3 years	105.6% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Effective Tax Rate (%) (%)	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—
FCF / Net Income (x)	0.80x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-453.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-854.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	1657.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-192.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-39.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	48.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-122.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-149.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-177.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-173.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-46.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-377.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	—	—	—	-243.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1725%)	-51.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-442%)	61.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+308%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Interest Coverage (x)	—	—	-116.54x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7031.38x Weak Weak Operating income divided by interest expense Optimal: > 5x	-41.61x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	—	—	$-18.90M	$-22.47M	$-53.66M	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$0.05	$0.09	$0.06	$0.01	$0.03	—	—
Basic EPS, GAAP (USD)	$-0.69	$-1.05	$-1.26	$-1.55	$-1.51	—	—
Free Cash Flow per Share (USD)	$-0.46	$-0.88	$-0.79	$-0.91	$-0.95	—	—
Book Value per Share (USD)	$0.08	$0.09	$-0.05	$0.57	$1.57	$-0.96	—
Tangible Book Value per Share (USD)	$0.08	$0.07	$-0.09	$0.48	$1.57	$-0.96	—
Basic Weighted Avg Shares (shares)	101.95M	50.52M	41.76M	36.17M	18.60M	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$8.89M	$1.62M	$-7.31M	$15.93M	$53.04M	—	—
Total Equity (USD)	$10.94M	$5.39M	$-2.31M	$23.05M	$54.74M	$-13.52M	$-5.31M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$4.71M	$4.35M	$2.43M	$377.00K	$500.00K	—	—
Depreciation Expense (USD)	$872.00K	$1.17M	$2.50M	$1.94M	$4.00K	—	—
Net Income, GAAP (USD)	$-58.01M	$-45.53M	$-52.67M	$-56.17M	$-28.08M	$-8.28M	—
Operating Cash Flow (USD)	$-46.48M	$-44.14M	$-32.82M	$-29.68M	$-17.67M	$-5.63M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 26 quarters

Lucid Diagnostics Inc.

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare LUCD with peers